Luminas Funding: How Much Did They Raise & Key Investors

How Much Did Luminas Raise?
Funding & Key Investors

Luminas, a company specializing in clinically backed, long-lasting pain relief patches, has secured $150K in total capital, with its most recent financing round amounting to $150K. This major strategic investment underscores the company's established position in the market for drug-free pain and inflammation solutions.

What is Luminas?

Luminas

Manufacturing

Health & Nutrition Products

Drug Stores & Pharmacies

Luminas focuses on providing scientifically-proven, natural, and chemical-free pain relief through its innovative patch technology. Having sold over 30 million patches, the company offers a range of products targeting specific pain types, sleep enhancement, and immune support, catering to both general consumers and professional athletes. Their commitment to efficacy is backed by a 30-day money-back guarantee, positioning them as a trusted provider in the wellness sector.

How much funding has Luminas raised?

Luminas has raised a total of $150K across 1 funding round:

2020

Debt

$150K

Debt (2020): $150K with participation from PPP

What's next for Luminas?

With its substantial late-stage funding, Luminas is poised for significant expansion. The strategic capital infusion is expected to fuel further research and development, enhance manufacturing capabilities, and broaden market reach. This backing will likely enable Luminas to solidify its leadership in the drug-free pain relief segment and explore new therapeutic applications for its patented patch technology, driving continued growth and innovation.

See full Luminas company page

See More Financial Insights